Experimental antibodies tested to keep HIV in check without daily pills
NCT ID NCT03526848
Summary
This early-stage study tested whether two lab-made antibodies (3BNC117 and 10-1074) could safely control HIV when people temporarily stopped their regular antiviral pills. Researchers gave 26 participants with well-controlled HIV seven antibody infusions and monitored if the virus stayed suppressed during the treatment break. The goal was to see if this approach could reduce the hidden HIV reservoir and delay the need to restart daily medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ragon Institute of MGH, MIT, and Harvard
Boston, Massachusetts, 02114, United States
-
The Rockefeller University
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.